The safety and efficacy of avapritinib in patients with advanced systemic mastocytosis

0 Views
administrator
administrator
07/09/23

Deepti Radia, MBBS, BSc, MRCPI, FRCPath, MSc Med Ed, Guy’s and St Thomas’ NHS Foundation Trust, London, UK, shares some insights into the safety and efficacy of avapritinib in patients with advanced systemic mastocytosis, and further highlights results from the PATHFINDER (NCT03580655) and EXPLORER (NCT02561988) trials. This interview took place at the third annual Texas MPN Workshop (TMW) 2022, held in San Antonio, TX.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next